Trimming Fat Upon Infection: Proteolytic Demyristoylation as a Novel Bacterial Pathogenic Strategy

dc.contributor.advisorSeemann, Joachimen
dc.contributor.committeeMemberChook, Yuh Minen
dc.contributor.committeeMemberOrth, Kimen
dc.contributor.committeeMemberAlto, Nealen
dc.creatorBurnaevskiy, Nikolayen
dc.date.accessioned2017-01-03T21:44:29Z
dc.date.available2017-01-03T21:44:29Z
dc.date.created2014-12
dc.date.issued2014-08-28
dc.date.submittedDecember 2014
dc.date.updated2017-01-03T21:39:28Z
dc.description.abstractHost-pathogen interaction is a complex process that involves an array of molecular tools on both sides of the conflict. In the light of growing antibiotics resistance, understanding of virulence factors utilized by pathogenic bacteria is crucial for developing better treatment for infectious diseases. Shigella spp are food-borne bacterial pathogens and are one of the leading causes of bacterial dysentery worldwide. Similarly to other gram-negative pathogens, Shigella injects effector proteins into an infected cell to control its responses. Dedicated type III secretion system delivers more than twenty effectors which highjack normal cell signaling by modulating activity of host proteins. By interfering with immune signaling, cytoskeleton, and other pathways, effector proteins promote survival of the bacterial pathogen. Inability to secrete effectors severely attenuates Shigella spp, pointing to the crucial role of these proteins in pathogenesis. Therefore, gaining an insight into the mechanism of action of secreted effectors may hold a key to better understanding and treatment of infectious diseases. Here I characterized the Shigella flexneri secreted virulence factor IpaJ. I found that IpaJ is a cysteine protease with novel specificity. IpaJ cleaves a myristoylated amino-terminal glycine of host proteins and therefore irreversibly delipidates them. Although IpaJ can target multiple host proteins, it strongly favors members of ADP-ribosylation factors family (ARF) and related ARF-like (ARL) proteins. By inactivating ARF and ARL proteins, IpaJ disrupts the Golgi structure and prevents secretion through general secretory pathway. I also found that by blocking protein export from the endoplasmic reticulum, IpaJ suppresses the activation of immune signaling pathways. In summary, I characterized a novel virulence factor of Shigella spp, IpaJ. I have shown that IpaJ promotes bacterial pathogenesis and therefore may be of potential interest for therapeutic interventions. The biochemical analysis of the enzyme provides the first look at the mechanism of substrate recognition and highlights the potential use of IpaJ as a research tool to study protein N-myristoylation and the mechanisms of membrane trafficking.en
dc.format.mimetypeapplication/pdfen
dc.identifier.oclc967597261
dc.identifier.urihttps://hdl.handle.net/2152.5/3941
dc.language.isoenen
dc.subjectADP-Ribosylation Factorsen
dc.subjectAntigens, Bacterialen
dc.subjectMyristic Aciden
dc.subjectProtein Processing, Post-Translationalen
dc.subjectShigella flexnerien
dc.subjectVirulence Factorsen
dc.titleTrimming Fat Upon Infection: Proteolytic Demyristoylation as a Novel Bacterial Pathogenic Strategyen
dc.typeThesisen
dc.type.materialtexten
thesis.degree.departmentGraduate School of Biomedical Sciencesen
thesis.degree.disciplineCell Regulationen
thesis.degree.grantorUT Southwestern Medical Centeren
thesis.degree.levelDoctoralen
thesis.degree.nameDoctor of Philosophyen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
BURNAEVSKIY-DISSERTATION-2014.pdf
Size:
6.43 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
LICENSE.txt
Size:
1.85 KB
Format:
Plain Text
Description: